Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron D Goldberg

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|July 24, 2019
Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeuticsDavid A Knorr, Aaron D Goldberg, Eytan M Stein, et al.
Genesis (New York, N.Y. : 2000)|September 30, 2014
Genome editing a mouse locus encoding a variant histone, H3.3B, to report on its expression in live animalsDuancheng Wen, Kyung-Min Noh, Aaron D Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2024
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AMLEunice S Wang, Aaron D Goldberg, Martin Tallman, et al.
Haematologica|December 1, 2022
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysisShai Shimony, Alon Rozental, Jan P Bewersdorf, et al.
American Journal of Hematology|September 27, 2025
Venetoclax in Combination With Pediatric-Inspired Chemotherapy in Adults With Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I TrialYannis K Valtis, David Nemirovsky, Andriy Derkach, et al.
Leukemia & Lymphoma|May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemiaThomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.
Leukemia & Lymphoma|June 28, 2021
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortalityMaximilian Stahl, Varun Narendra, Justin Jee, et al.
Cell|October 1, 2013
Hira-dependent histone H3.3 deposition facilitates PRC2 recruitment at developmental loci in ES cellsLaura A Banaszynski, Duancheng Wen, Scott Dewell, et al.
Blood Neoplasia|June 24, 2025
Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemiaKuo-Kai Chin, Yannis Valtis, Andriy Derkach, et al.
American Journal of Hematology|March 15, 2025
Venetoclax-Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC-DATAML-MSKCC Retrospective StudyCassandre Petit, Jules Higue, Ziyad Acheaibi, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|July 24, 2019
Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeuticsDavid A Knorr, Aaron D Goldberg, Eytan M Stein, et al.
Genesis (New York, N.Y. : 2000)|September 30, 2014
Genome editing a mouse locus encoding a variant histone, H3.3B, to report on its expression in live animalsDuancheng Wen, Kyung-Min Noh, Aaron D Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2024
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AMLEunice S Wang, Aaron D Goldberg, Martin Tallman, et al.
Haematologica|December 1, 2022
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysisShai Shimony, Alon Rozental, Jan P Bewersdorf, et al.
American Journal of Hematology|September 27, 2025
Venetoclax in Combination With Pediatric-Inspired Chemotherapy in Adults With Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I TrialYannis K Valtis, David Nemirovsky, Andriy Derkach, et al.
Leukemia & Lymphoma|May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemiaThomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.
Leukemia & Lymphoma|June 28, 2021
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortalityMaximilian Stahl, Varun Narendra, Justin Jee, et al.
Cell|October 1, 2013
Hira-dependent histone H3.3 deposition facilitates PRC2 recruitment at developmental loci in ES cellsLaura A Banaszynski, Duancheng Wen, Scott Dewell, et al.
Blood Neoplasia|June 24, 2025
Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemiaKuo-Kai Chin, Yannis Valtis, Andriy Derkach, et al.
American Journal of Hematology|March 15, 2025
Venetoclax-Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC-DATAML-MSKCC Retrospective StudyCassandre Petit, Jules Higue, Ziyad Acheaibi, et al.
Pageof 7